A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804

Clinical trial NCT03118570 · COMPLETED

Trial details

NCT number: NCT03118570
Sponsor: Ultragenyx Pharmaceutical Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteogenesis Imperfecta, Type I Osteogenesis Imperfecta Type III Osteogenesis Imperfecta Type IV

Start date: 2017-09-11
Primary completion: 2019-10-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.